ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,944Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1155

$809K Total Retail Price of All Prescriptions

Rank: 3 out of 1155

601 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 601 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 601 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 10,532 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 575 525 1 3
LEVOTHYROXINE SODIUM 548 411 2 2
HYDROCODONE-ACETAMINOPHEN 464 344 S3 3 4
LISINOPRIL 456 368 4 1
AMLODIPINE BESYLATE 410 350 5 6
OMEPRAZOLE 408 261 6 5
METOPROLOL TARTRATE 355 325 7 14
PRAVASTATIN SODIUM 322 271 8 20
FUROSEMIDE 289 228 9 8
SERTRALINE HCL 275 198 10 24
ZOLPIDEM TARTRATE 256 188 11 21
ALENDRONATE SODIUM 249 227 12 25
OXYCODONE HCL 245 164 S2 13 23
LOVASTATIN 220 155 14 13
CITALOPRAM HBR 213 202 15 19
METOPROLOL SUCCINATE 186 156 16 17
METFORMIN HCL 180 156 17 7
ATORVASTATIN CALCIUM 166 154 18 12
WARFARIN SODIUM 160 129 19 11
TRAZODONE HCL 146 101 20 22
ATENOLOL 145 87 21 10
CARVEDILOL 142 130 22 28
CYMBALTA 127 86 23 46
LOSARTAN POTASSIUM 127 105 23 18
GABAPENTIN 124 79 25 15
POTASSIUM CHLORIDE 122 109 26 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 88 27 26
TRAMADOL HCL 112 71 28 32
DICLOFENAC SODIUM 112 43 28 93
METHADONE HCL 107 47 S2 30 50
HYDROCHLOROTHIAZIDE 107 96 30 9
ALLOPURINOL 101 98 32 29
TAMSULOSIN HCL 100 99 33 27
MORPHINE SULFATE ER 91 55 S2 34 36
GLIMEPIRIDE 89 73 35 43
PROMETHAZINE HCL 88 38 R 36 105
LANTUS 83 63 37 39
PROAIR HFA 82 66 38 31
FENOFIBRATE 82 46 38 83
DONEPEZIL HCL 82 73 38 41
CARBIDOPA-LEVODOPA 81 60 41 124
TRIAMTERENE-HYDROCHLOROTHIAZID 81 81 41 89
FLUTICASONE PROPIONATE 80 58 43 37
TRIAMTERENE-HCTZ 80 59 43 51
PREDNISONE 77 57 45 40
ADVAIR DISKUS 74 65 46 35
VENTOLIN HFA 69 31 47 84
LANTUS SOLOSTAR 64 52 48 96
ACTONEL 63 49 49 163
CYCLOBENZAPRINE HCL 62 24 R 50 38
VENLAFAXINE HCL ER 61 26 51 68
NAMENDA 61 57 51 67
DOXAZOSIN MESYLATE 57 38 53 56
PANTOPRAZOLE SODIUM 57 33 53 47
CLOPIDOGREL 56 56 55 70
MELOXICAM 55 43 56 52
NEXIUM 54 37 57 98
PAROXETINE HCL 53 40 58 48
MICARDIS 53 53 58 169
MORPHINE SULFATE 52 26 S2 60 123
ISOSORBIDE MONONITRATE ER 51 47 61 87
FLUOXETINE HCL 51 32 61 30
PLAVIX 51 51 61 115
BUPROPION HCL SR 50 0 64 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.